The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Cancer Research and Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4103/0973-1482.143334PMID 25879330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions.

  2011cited by this paper
• Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil.

  2010cited by this paper
• ABC efflux pump-based resistance to chemotherapy drugs.

  2009cited by this paper
• An overview of cancer multidrug resistance: a still unsolved problem

  2008cited by this paper
• DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formation.

  2007cited by this paper
• Chemotherapy-induced resistance by ATP-binding cassette transporter genes.

  2007cited by this paper
• Chemotherapy resistance in osteosarcoma: current challenges and future directions

  2006cited by this paper
• Expression profiles of osteosarcoma that can predict response to chemotherapy.

  2005cited by this paper
• Accumulation and Oriented Transport of Ampicillin in Caco-2 Cells from Its Pivaloyloxymethylester Prodrug, Pivampicillin

  2005cited by this paper
• Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain.

  2004cited by this paper
• The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation.

  2004cited by this paper
• Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy

  2004cited by this paper
• Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane

  2003cited by this paper
• Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues.

  2002cited by this paper
• Expression of MRP4 Confers Resistance to Ganciclovir and Compromises Bystander Cell Killing*

  2002cited by this paper
• Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2).

  2002cited by this paper
• Mammalian ABC transporters in health and disease.

  2002cited by this paper
• Expression and localization of multidrug resistant protein mrp2 in rat small intestine.

  2000cited by this paper
• Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells.

  2000cited by this paper
• P-glycoprotein--a mediator of multidrug resistance in tumour cells.

  1996cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin.

  1990cited by this paper

• Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma

  2024cites this paper
• The association of ABC proteins with multidrug resistance in cancer.

  2024cites this paper
• Exploring Bile Acid Transporters As Key Players In Cancer Development And Treatment: Evidence From Preclinical And Clinical Studies.

  2024cites this paper
• ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling

  2024cites this paper
• Advancement in transporter-oriented nanoplatforms for cancer therapy

  2023cites this paper
• Progress and challenges of multidrug resistance proteins in diseases.

  2022cites this paper
• Hsa_circ_0001982 promotes the proliferation, invasion, and multidrug resistance of osteosarcoma cells

  2022cites this paper
• Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?

  2021cites this paper
• miRNAs Mediated Drug Resistance in Hematological Malignancies.

  2021cites this paper
• Multidrug resistance protein 4 (MRP4/ABCC4) is overexpressed in clear cell renal cell carcinoma (ccRCC) and is essential to regulate cell proliferation.

  2020cites this paper
• p53 haploinsufficiency and increased mTOR signaling define a subset of aggressive hepatocellular carcinoma.

  2020cites this paper
• Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy

  2020cites this paper
• Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells

  2019cites this paper
• Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells

  2019cites this paper
• MRP4/ABCC4 As a New Therapeutic Target: Meta-Analysis to Determine cAMP Binding Sites as a Tool for Drug Design.

  2019cites this paper
• Mechanisms of Anticancer Drug Resistance in Hepatoblastoma

  2019cites this paper
• SIRT7 depletion inhibits cell proliferation, migration, and increases drug sensitivity by activating p38MAPK in breast cancer cells

  2018cites this paper
• IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4

  2018cites this paper
• Identification of gene expression profiles associated with doxorubicin resistance in paired doxorubicin-resistant and doxorubicin-sensitive osteosarcoma cell lines

  2017cites this paper
• R-Flurbiprofen Traps Prostaglandins within Cells by Inhibition of Multidrug Resistance-Associated Protein-4

  2016cites this paper
• Detection of MDR1 mRNA expression with optimized gold nanoparticle beacon

  2016cites this paper
• Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.

  2015cites this paper
• CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin.

  2015cites this paper
• The Pharmacological and Physiological Role of Multidrug-Resistant Protein 4

  2015cites this paper